This
section contains market reviews covering the broad range of sophisticated
products that VRG Technologies is working towards.
All of the markets reviewed have shown significant growth and are well
positioned for continued success. Summary figures are presented below.
INDUSTRIAL
APPLICATIONS FOR ENZYMES: WORLDWIDE MARKET FORECAST FOR 2002: $1.8 BILLION
ADVANCED WOUND CARE BUSINESS FORECAST FOR 2005: 3.06 BILLION
APPLICATION
MARKETS FOR GENOMIC-BASED PRODUCTS AND SERVICES IN 2004 $
8.2 BILLION
WORLDWIDE
SALES OF THERAPEUTIC AND DIAGNOSTIC IMAGING ANTIBODIES IN 2004 $9.9
WORLDWIDE
MARKET FOR PRESCRIPTION DRUGS TO TREAT SELECTED IMMUNE DISEASES IN 2003
$44.5 BILLION
The
U.S. Market for Rx-to-OTC Switched Ingredients, through 2005 $12.0 BILLION
Worldwide
Production OF PROTEIN in 2004 (Grams) - 1,150,573,386 Sales $43.1 BILLION
CANCER
TREATMENT AND DIAGNOSTICS INDUSTRY MARKET IN 2003 $25.0 BILLION
Worldwide
Revenues for Apoptosis-related Products in 2005 ($ Millions) - 529.1
Worldwide
Market for Prophylactic and Therapeutic Vaccines, through 2006 $9.9
BILLION
ESTIMATED
VALUE OF TOTAL U.S. ADVANCED POTABLE WATER TREATMENT TECHNOLOGY IN 2003 $5.9
BILLION
WORLDWIDE
MARKET FOR DRUGS, 1998-2003 ($ Billions) – 271.2
Advanced
drug delivery systems, through 2005 $27.4 BILLION
Data and analysis
provided courtesy of BUSINESS COMMUNICATIONS COMPANY, INC., 25 Van Zant Street, Norwalk, CT
06855, Telephone: (203) 853-4266; ext. 309, Email: publisher@bccresearch.com
